MétaCan
Menu
← Back to cohort
Record W2789705127 · doi:10.1093/jcag/gwy008.324

A323 A PERSONALIZED MEDICINE APPROACH TO THE ROLE OF RECTAL INDOMETHACIN IN PREVENTING POST -ERCP PANCREATITIS: A META- ANALYSIS OF AGGREGATE SUBGROUP DATA

2018· article· en· W2789705127 on OpenAlexaff
Mohammad Yaghoobi, Mohammed Attieh Alzahrani, Julia McNabb‐Baltar, Myriam Martel, F Tse, Alan Barkun

Bibliographic record

VenueJournal of the Canadian Association of Gastroenterology · 2018
Typearticle
Languageen
FieldMedicine
TopicGastroesophageal reflux and treatments
Canadian institutionsMcGill UniversityMcGill University Health CentreMontreal General HospitalMcMaster University
Fundersnot available
KeywordsMedicineJadad scalePlaceboSubgroup analysisMeta-analysisInternal medicineRandomized controlled trialPancreatitisEndoscopic retrograde cholangiopancreatographyPopulationGastroenterologyCochrane Library

Abstract

fetched live from OpenAlex

Despite initial evidence in the literature favoring rectal indomethacin in preventing post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP), recent studies have been controversial in supporting its universal use, in part due to varying patient selection. To identify optimal patient subgroups who might benefit the most from rectal indomethacin. A comprehensive electronic literature search was done. Randomized controlled trials (RCTs) comparing rectal indomethacin and placebo in preventing PEP. Methodological quality was assessed by the Cochrane risk of bias tool as well as Jadad scale. Statistical heterogeneity was assessed. Several subgroup, sensitivity and individual participant data were completed based on specific risk factors or patient characteristics to characterize patient populations who benefit most from the intervention. The rate of PEP. A total of seven out of 336 trials published between 2007 and 2016 (n=3096) were included. The pooled proportion estimate of PEP rate was 5.6% with indomethacin and 8.7% with placebo. Random model meta-analysis showed the overall rate of pancreatitis was significantly lower with rectal indomethacin [OR=0.54(0.36–0.82), number needed to treat =19]. In subgroup analysis, the difference was not significantly different in an unselected population, but was when restricting the analysis to high-risk patients [OR: 0.42 (0.27–0.66)]. Subgroup analysis showed that administering rectal indomethacin before rather than during or after procedure significantly reduced the rate of PEP [OR:0.53(0.37–076)]. Individual participant data showed rectal indomethacin significantly prevented PEP in patients with sphincter of Oddi dysfunction (SOD) [0.47(0.28–0.77)] and those undergoing biliary sphincterotomy [OR:0.72 (0.52–0.99)], but not in those undergoing pre-cut or pancreatic sphincterotomy, or prophylactic pancreatic stent placement. Rectal indomethacin also significantly decreased the rate of moderate to severe PEP in all patients [OR: 0.47 (0.28–0.79)]. Sensitivity analysis showed that the lower quality of studies favored indomethacin. Rectal indomethacin significantly reduces the risk of PEP in high-risk, and more specifically SOD patients; it decreases the occurrence of moderate to severe PEP in all patients, only if given pre-procedure. Additional data are needed to assess the additional contribution of prophylactic pancreatic stent placement. None

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.031
metaresearch head score (Gemma)0.048
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Meta-analysis · Consensus signal: Meta-analysis
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.031
Threshold uncertainty score0.166

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0310.048
Meta-epidemiology (narrow)0.0030.001
Meta-epidemiology (broad)0.0160.068
Bibliometrics0.0070.005
Science and technology studies0.0000.001
Scholarly communication0.0040.002
Open science0.0020.002
Research integrity0.0030.003
Insufficient payload (model declined to judge)0.0060.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.030
GPT teacher head0.285
Teacher spread0.254 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designMeta-analysis
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2018
Admission routes1
Has abstractyes

Explore more

Same venueJournal of the Canadian Association of Gastroenterology→Same topicGastroesophageal reflux and treatments→French-language works237,207→